age limit for glp 1 Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection | Current Obesity Reports GLP-1 Weight-Loss Drug Demonstration Begins

Description

Trujillo, J.M., Nuffer, W., and Smith, B.A

Combined GLP-1, oxyntomodulin, and peptide YY improves body weight and glycemia in obesity and prediabetes/type 2 diabetes: a randomized, single-blinded, placebo-controlled study

Patients experiencing recurrent or persistent injection site reactions should discuss these concerns with their prescribing clinician, who may consider alternative formulations, dose adjustments, or switching to a different medication if symptoms significantly impact quality of life or treatment adherence

It is also not approved for individuals with type 1 diabetes.7 Liraglutide (Saxenda, Victoza) Liraglutide is a once daily injectable GLP-1 RA that can be prescribed for both glycemic control in T2DM and chronic weight management

Ozempic (semaglutide) was originally developed for type 2 diabetes, but off-label prescribing for weight loss has surged since clinical trials showed 15% body weight reduction in non-diabetic patients